Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity
Abstract Introduction Advanced non-small cell lung cancer (NSCLC) is still a therapeutic challenge as the 5-year survival is under 30%. The optimal treatment regimen is still under debate. Hypothesis Neo adjuvant (NA) treatment given pre-pneumonectomy does not increase surgical complexity or peri-OP...
Main Authors: | Dan Aravot, Yaron D. Barac, Efrat Krutzwald-Josefson, Aaron M. Allen, Dov Flex, Nir Peled, Mordechai R. Kramer, Yuri Peysakhovich, Milton Saute |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | Journal of Cardiothoracic Surgery |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13019-018-0829-z |
Similar Items
-
Correction to: Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity
by: Dan Aravot, et al.
Published: (2019-02-01) -
Comparison of the prognosis of neoadjuvant chemoradiotherapy treatment with surgery alone in esophageal carcinoma: a meta-analysis
by: Ma HF, et al.
Published: (2018-06-01) -
Extended Robotic Pulmonary Resections
by: Joshua A. Scheinerman, et al.
Published: (2021-02-01) -
Feasibility study on pre or postoperative accelerated radiotherapy (POP-ART) in breast cancer patients
by: Hans Van Hulle, et al.
Published: (2020-10-01) -
Adjuvant Chemo-Radiotherapy versus Chemotherapy in Pancreatic Carcinoma
by: Shimaa Attia, et al.
Published: (2017-06-01)